Towards gene therapy of diabetes mellitus

Fred Levine*, Gil Leibowitz

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations

Abstract

A definitive treatment for diabetes mellitus will be one that maintains a normal blood glucose concentration in the face of fluctuating dietary intake. To accomplish this, there must be mechanisms to sense the amount of blood glucose coupled to rapid release of the right amount of insulin. While mechanical devices to accomplish this are being developed, ultimately the best approach is likely to be based on genetic modification of cells. These could be pancreatic β-cells, which are the only cells that produce insulin, or other cells that are involved in the pathogenesis of diabetes. Although definitive treatment of diabetes using genetically modified cells is a long- term goal, much progress is being made. This review discusses various approaches to modifying cells genetically, both in vitro and in vivo, for the treatment of diabetes.

Original languageAmerican English
Pages (from-to)165-171
Number of pages7
JournalMolecular Medicine Today
Volume5
Issue number4
DOIs
StatePublished - 1 Apr 1999
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by grants from the Juvenile Diabetes Foundation and the Stern Foundation.

Fingerprint

Dive into the research topics of 'Towards gene therapy of diabetes mellitus'. Together they form a unique fingerprint.

Cite this